Dyne Therapeutics Inc (NASDAQ: DYN) is -75.49% lower on its value in year-to-date trading and has touched a low of $6.36 and a high of $47.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DYN stock was last observed hovering at around $9.52 in the last trading session, with the day’s gains setting it 2759990.48%.
Currently trading at $2760000.0, the stock is -28.50% and -26.09% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 9.32 million and changing -8.82% at the moment leaves the stock -55.41% off its SMA200. DYN registered -63.16% loss for a year compared to 6-month loss of -64.53%. The firm has a 50-day simple moving average (SMA 50) of $11.7445 and a 200-day simple moving average (SMA200) of $19.466776.
The stock witnessed a -27.42% gain in the last 1 month and extending the period to 3 months gives it a -17.02%, and is -18.34% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.91% over the week and 7.58% over the month.
Dyne Therapeutics Inc (DYN) has around 191 employees, a market worth around $986.63M and $0.00M in sales. Distance from 52-week low is 36.48% and -81.71% from its 52-week high. The company has generated returns on investments over the last 12 months (-53.42%).
The EPS is expected to shrink by -16.69% this year.
Dyne Therapeutics Inc (DYN) Top Institutional Holders
281.0 institutions hold shares in Dyne Therapeutics Inc (DYN), with institutional investors hold 110.86% of the company’s shares. The shares outstanding are 113.63M, and float is at 85.23M with Short Float at 24.20%. Institutions hold 110.24% of the Float.
The top institutional shareholder in the company is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC with over 8.02 million shares valued at $283.03 million. The investor’s holdings represent 8.6697% of the DYN Shares outstanding. As of 2024-06-30, the second largest holder is FCPM III SERVICES B.V. with 7.85 million shares valued at $276.86 million to account for 8.4808 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 7.39 million shares representing 7.9853% and valued at over $260.69 million, while RTW INVESTMENTS, LP holds 6.9044 of the shares totaling 6.39 million with a market value of $225.4 million.
Dyne Therapeutics Inc (DYN) Insider Activity
Still, SEC filings show that on Jun 05 ’25, Cox John (CEO & President) disposed off 4,060 shares at an average price of $13.35 for $54201.0. The insider now directly holds 142,179 shares of Dyne Therapeutics Inc (DYN).
